Interferon as adjuvant treatment for melanoma

Lancet. 2002 Sep 14;360(9336):878. doi: 10.1016/S0140-6736(02)09986-5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Chemotherapy, Adjuvant
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Melanoma / drug therapy*
  • Melanoma / mortality
  • Melanoma / secondary
  • Recombinant Proteins
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / mortality
  • Survival Analysis
  • Treatment Outcome

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins